"Silvanols" in cooperation with Japanese pharma company „Takeda Pharmaceutical Company Limited” representatives  in Austria „Takeda Pharma Ges.m.g.H.” has started export of leg vein product Venocaps to Austria. In the end of April „Takeda Pharma Ges.m.g.H.” have received 20000 packages of Venocaps and it is planned to send at least as much packages more.

"Cooperation with Takeda which is one of the world's leading pharmaceutical companies is a serious achievment of our specialists and opens new perspectives of meeting new potential partners. Austrian pharma market is characterized by its stability, high purchase power of the denizens as well as the high requiremets of quality, which our products can definetely satisfy. We will continue on working to increase the share of export markets in European countries." Says the "Silvanols" Chairman of the Board Arjoms Borcovs.

"Silvanols" earned the interest of Takeda in the „CPhI Worldwide 2013”. The first talks about the possible cooperation were followed by an audit by Takeda experts in the manufacturing facilies where the quality systems, the manufacturing process and the products' compliance with the highest quality requirements were evaluated. After the audit Takeda representatives decided to start cooperation with silvanols and add the natural product Venocaps to their extensive product portfolio.